Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Submitted by
admin
on October 1, 2014 - 8:09am
Source:
Bidness Etc.
News Tags:
tax inversions
intellectual property
Gilead Sciences
Alexion
Headline:
Biopharmaceutical companies are now increasingly relocating patent rights to overseas markets to lower their tax burden
Do Not Allow Advertisers to Use My Personal information
